02 nov 2020
malattie della pelle nuovi orizzonti e coronavirus
Otto sale congressuali virtuali in cui si svolgeranno le diverse sessioni anche in contemporanea. Oltre 330 relazioni a disposizione dei partecipanti, 37 corsi ECM live e numerosi non ECM, più una serie di sessioni on demand che saranno tutte consultabili ben oltre la fine dei lavori.
29 ott 2020
Addressing unmet patient needs in pruritus: upcoming EADV Virtual presentations and abstracts
Embargoed until 07:00 CET, Friday 30th October 2020
29 ott 2020
Cutaneous adverse reactions to anti–PD-1 treatment. A systematic review
A systematic review
29 ott 2020
Expanding treatment options for rosacea
Such a high-quality cluster randomized controlled trial involving 2040 nurses across the UK.
29 ott 2020
Dermoscopy of genital diseases: a review
A review
27 ott 2020
94° Congresso Nazionale SIDeMaST
Dal 3 Novembre online ...
21 ott 2020
I nevi plantari sono più pericolosi rispetto agli altri nevi?
È vero che…. I nevi plantari sono più pericolosi rispetto agli altri nevi?
20 ott 2020
Immunogenicity of biologic therapies in psoriasis Myths, facts and a suggested approach
With biologic drugs dominating the therapeutic space for severe immune‐mediated inflammatory disease, it is critical for clinicians to be familiar with the concept of drug immunogenicity, with the potential for our patients to develop anti‐drug antibodies (ADA) of clinical relevance.
20 ott 2020
Long‐term effectiveness of dupilumab up to 52 weeks in atopic dermatitis in 253 adult patients
Dupilumab, an inhibitor of interleukin (IL)‐4/13 activity, is a biological agent approved for the treatment of moderate‐to‐severe atopic dermatitis (AD)
20 ott 2020
Association Between Topical Calcineurin Inhibitor Use and Keratinocyte Carcinoma Risk Among Adults With Atopic Dermatitis
Is exposure to topical calcineurin inhibitors among adult patients with atopic dermatitis associated with increased keratinocyte carcinoma risk?
15 ott 2020
L’infiammazione “nascosta” della psoriasi
Nelle fasi pre e post lesionali non si vede, ma si può comunque contrastare?
15 ott 2020
L’infiammazione Subclinica Nella Psoriasi
L’infiammazione subclinica della cute psoriasica pre- e post-lesionali: un nuovo ambito di intervento
11 ott 2020
No increased risk of melanoma among patients with psoriasis treated with methotrexate
Patients with an impaired immune system have higher risk for melanoma, the most dangerous type of skin cancer, and a worse prognosis.
11 ott 2020
New jak inhibitors for the treatment of psoriasis and psoriatic arthritis
Psoriasis is a common inflammatory skin disease that can be associated with various pathological conditions among which arthritis is a frequent comorbidity.
11 ott 2020
A retrospective cohort study of the diagnostic value of different subtypes of atypical pigment network on dermoscopy
Atypical network encompasses several patterns.
06 ott 2020
Challenges and new perspectives in the treatment of advanced cutaneous squamous cell carcinoma
an expert opinion
06 ott 2020
Systematic Review of Mohs Micrographic Surgery in Children
Identifying Challenges and Practical Considerations for Successful Application
06 ott 2020
What are the best endpoints for Eczema Area and Severity Index and Scoring Atopic Dermatitis in clinical practice?
A prospective observational study
06 ott 2020
Convocazione Assemblea Ordinaria Dei Soci 2020
Avviso di convocazione dell’Assemblea Ordinaria dei Soci SIDeMaST (4 novembre 2020)
05 ott 2020
Pazienti in terapia con farmaci biologici e vaccinazione anti-influenzale
Pazienti affetti da Psoriasi, Dermatite Atopica, Melanoma e Carcinoma Squamocellulare